Downregulation of HLA class II molecules by G1896A pre-core mutation in chronic hepatitis B virus infection

Viral Immunology

Volumn 22, Issue 5, 2009, Pages 295-300

  Mohamadkhani, Ashraf ^a   Sotoudeh, Masoud ^a   Bowden, Scott ^b   Poustchi, Hossein ^a   Jazii, Ferdos Rastgar ^c   Sayehmiri, Kourosh ^a   Malekzadeh, Reza ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^c NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HLA ANTIGEN CLASS 2; VIRUS DNA;

ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; MALE; VIRUS MUTATION;

ADULT; ANTIGENS, VIRAL; DNA, VIRAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENES, MHC CLASS II; GENOME, VIRAL; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE EVASION; LIVER; MALE; MIDDLE AGED; POINT MUTATION;

HEPATITIS B VIRUS;

EID: 70350093026     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2009.0031     Document Type: Article

References (30)

1. Bachmann M F, Lutz MB, Layton GT, Harris SJ, Fehr T, Rescigno M, and Ricciardi-Castagnoli P: Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes. Eur J Immunol 1996;26:2595-2600.
2. Ballare M, Lavarini C, Brunetto MR, Petruzzelli E, Dovis M, Molino G, and Bonino F: Relationship between the intrahepatic expression of 'e' and 'c' epitopes of the nucleocapsid protein of hepatitis B virus and viraemia. Clin Exp Immunol 1989;75:64-69.
3. Barbatis C, Kelly P, Greveson J, Heryet A, and McGee JO: Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man. J Clin Pathol 1987;40:879-884.
4. Barone M, Spano D, D'Apolito M, et al.: Gene expression analysis in HBV transgenic mouse liver: A model to study early events related to hepatocarcinogenesis. Mol Med 2006;12:115-123.
5. Brunetto MR, Stemler M, Schodel F, et al.: Identification of HBV variants which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol 1989;21:151-154.
6. Carman WF, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, and Thomas HC: Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989;2:588-591.
7. Chang JJ, and Lewin SR: Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 2007;85:16-23.
8. Chu CM, and Liaw YF: Immunohistological study of intrahepatic expression of hepatitis B core and E antigens in chronic type B hepatitis. J Clin Pathol 1992;45:791-795.
9. Cohen AD and Shoenfeld Y: The viral-autoimmunity relationship. Viral Immunol 1995;8:1-9.
10. Evans AA, and LW: Epidemiology of hepatitis B. In: Viral Hepatitis. (Zuckerman AJ, and Thomas HC, eds.). 1998, pp. 107-114.
11. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, Realdi G, and Ruol A: Natural history and prognostic factors for chronic hepatitis type B. Gut 1991;32: 294-298.
12. Filaci G, Contini P, Fravega M, et al.: Apoptotic DNA binds to HLA class II molecules inhibiting antigen presentation and participating in the development of anti-inflammatory functional behavior of phagocytic macrophages. Hum Immunol 2003;64:9-20.
13. Filaci G, Contini P, Grasso I, et al.: Double-stranded deoxyribonucleic acid binds to HLA class II molecules and inhibits HLA class II-mediated antigen presentation. Eur J Immunol 1998;3968-3979. (Pubitemid 28558627)
14. Fouillot N, Tlouzeau S, Rossignol JM, and Jean-Jean P: Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation. J Virol 1993; 67:4886-4895.
15. Ishaka K, Baptistab A, Bianchic L, Callead F, Grootee JD, and Gudatf F: Histological grading and staging of chronic hepatitis. J Hepatology 1995;22:696-699.
16. Jilbert AR, Freiman JS, Burrell CJ, Holmes M, Gowans EJ, Rowland R, Hall P, and Cossart YE: Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver. Gastroenterology 1988;95: 1375-1382.
17. Jung MC and Pape GR: Immunology of hepatitis B infection. Lancet Infect Dis 2002;2:43-50.
18. Ksiaa L, Ayed-Jendoubi S, Sfar I, Gorgi Y, Najjar HA, Abdallah TB, and Ayed K: Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II. Viral Immunol 2007;20:312-319.
19. Lamberts C, Nassal M, Velhagen I, Zentgraf H, and Schroder CH: Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis. J Virol 1993;67:3756-3762.
20. Li JS, Tong SP, Wen YM, Vitvitski L, Zhang Q, and Trepo C: Hepatitis B virus genotype A rarely circulates as an HBeminus mutant: possible contribution of a single nucleotide in the precore region. J Virol 1993;67:5402-5410.
21. Lindh M, Horal P, Dhillon AP, and Norkrans G: Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B. J Viral Hepatol 2000;7: 258-267.
22. Lindh M, Dhillon AP, Furuta Y, and Norkrans G: Hepatitis B virus carriers without pre-core mutations in hepatitis B e antigen-negative stage show more severe liver damage. Hepatology 1996;24:494-501.
23. Lok AS, and Greene S: Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci USA 1994;91:4077-4081.
24. Moutaftsi M, Mehl AM, Borysiewicz LK, and Tabi Z: Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 2002;99: 2913-12121
25. Pollack JR and Ganem D: An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J Virol 1993;67:3254-3263.
26. Poustchi H, Mohamadkhani A, Bowden S, et al.: Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat 2008;15:753-760.
27. Sumi H, Seki N, Arai M, Imazeki F, Kurihara T, and Kanda T: Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology 2003;37: 19-26.
28. Tong SP, Diot C, Gripon P, Li J, Vitvitski L, Trepo C, and Guguen-Guillouzo C: In vitro replication competence of a cloned hepatitis B virus variant with a nonsense mutation in the distal pre-C region. Virology 1991;181:733-737.
29. Werle-Lapostolle B, Bowden S, Locarnini S, et al.: Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004;126:1750-1758.
30. Yuan TT, Faruqi A, Shih JW, and Shih C: The mechanism of natural occurrence of two closely linked HBV precore predominant mutations. Virology 1995;211:144-156.